BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND PDCD1, CD279, PD-1, PD1, SLEB2, hPD-1, hPD-l, hSLE1 AND Staging
9 results:

  • 1. Temporal bone management in external and middle ear carcinoma.
    Gowrishankar S; Borsetto D; Marinelli J; Panizza B
    Curr Opin Otolaryngol Head Neck Surg; 2024 Apr; 32(2):138-142. PubMed ID: 38193562
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Safety and efficacy of laparoscopic surgery in locally advanced gastric cancer patients with neoadjuvant chemotherapy combined with immunotherapy].
    Lv JB; Yin YP; Zhang P; Cai M; Chen JH; Li W; Li G; Wang Z; Wang GB; Tao KX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jan; 26(1):84-92. PubMed ID: 36650004
    [No Abstract]    [Full Text] [Related]  

  • 3. Tumor Growth Rate in Spinal Giant Cell Tumors of bone and Association With the Immune Microenvironment and Denosumab Treatment Responsiveness: A Multicenter Study.
    Zheng BW; Zheng BY; Niu HQ; Yang YF; Zhu GQ; Li J; Zhang TL; Zou MX
    Neurosurgery; 2023 Mar; 92(3):524-537. PubMed ID: 36409294
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The "Great Debate" at Melanoma Bridge 2021, December 2nd-4th, 2021.
    Ascierto PA; Warner AB; Blank C; Caracò C; Demaria S; Gershenwald JE; Khushalani NI; Long GV; Luke JJ; Mehnert JM; Robert C; Rutkowski P; Tawbi HA; Osman I; Puzanov I
    J Transl Med; 2022 May; 20(1):200. PubMed ID: 35538491
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC.
    Mazzaschi G; Milanese G; Pagano P; Madeddu D; Gnetti L; Trentini F; Falco A; Frati C; Lorusso B; Lagrasta C; Minari R; Ampollini L; Silva M; Sverzellati N; Quaini F; Roti G; Tiseo M
    Lung Cancer; 2020 Jun; 144():30-39. PubMed ID: 32361033
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Patterns of distant metastases in 215 Merkel cell carcinoma patients: Implications for prognosis and surveillance.
    Lewis CW; Qazi J; Hippe DS; Lachance K; Thomas H; Cook MM; Juhlin I; Singh N; Thuesmunn Z; Takagishi SR; McEvoy A; Doolittle-Amieva C; Bhatia S; Paulson KG; O'Malley RB; Wang CL; Nghiem P
    Cancer Med; 2020 Feb; 9(4):1374-1382. PubMed ID: 31883234
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Integrated genomic characterization of oral carcinomas in post-hematopoietic stem cell transplantation survivors.
    Hanna GJ; Kofman ER; Shazib MA; Woo SB; Reardon B; Treister NS; Haddad RI; Cutler CS; Antin JH; Van Allen EM; Uppaluri R; Soiffer RJ
    Oral Oncol; 2018 Jun; 81():1-9. PubMed ID: 29884406
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. CD4+ T Cells are Exhausted and Show Functional Defects in Chronic Lymphocytic Leukemia.
    Allahmoradi E; Taghiloo S; Tehrani M; Hossein-Nattaj H; Janbabaei G; Shekarriz R; Asgarian-Omran H
    Iran J Immunol; 2017 Dec; 14(4):257-269. PubMed ID: 29276179
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study.
    Agostinelli C; Gallamini A; Stracqualursi L; Agati P; Tripodo C; Fuligni F; Sista MT; Fanti S; Biggi A; Vitolo U; Rigacci L; Merli F; Patti C; Romano A; Levis A; Trentin L; Stelitano C; Borra A; Piccaluga PP; Hamilton-Dutoit S; Kamper P; Zaucha JM; Małkowski B; Kulikowski W; Tajer J; Subocz E; Rybka J; Steidl C; Broccoli A; Argnani L; Gascoyne RD; d'Amore F; Zinzani PL; Pileri SA
    Lancet Haematol; 2016 Oct; 3(10):e467-e479. PubMed ID: 27692305
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.